IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,177,000 | -87.3% | 49,661 | -84.5% | 1.45% | +141.2% |
| Q2 2016 | $9,238,000 | +39.8% | 320,552 | +55.4% | 0.60% | +50.4% |
| Q1 2016 | $6,606,000 | -16.2% | 206,313 | +11.9% | 0.40% | -13.8% |
| Q4 2015 | $7,881,000 | +36.3% | 184,317 | +12.2% | 0.46% | +62.5% |
| Q3 2015 | $5,782,000 | -31.9% | 164,218 | -11.2% | 0.28% | -22.8% |
| Q2 2015 | $8,496,000 | -14.0% | 185,032 | -12.2% | 0.37% | -7.3% |
| Q1 2015 | $9,874,000 | -16.4% | 210,687 | -43.5% | 0.40% | -16.9% |
| Q4 2014 | $11,807,000 | -45.8% | 372,696 | -59.4% | 0.48% | -40.3% |
| Q3 2014 | $21,783,000 | +199.1% | 918,733 | +278.4% | 0.80% | +225.1% |
| Q2 2014 | $7,282,000 | +4.9% | 242,814 | -7.6% | 0.25% | +42.0% |
| Q1 2014 | $6,944,000 | -4.7% | 262,841 | -9.3% | 0.17% | -3.9% |
| Q4 2013 | $7,288,000 | -47.2% | 289,898 | -57.0% | 0.18% | -50.8% |
| Q3 2013 | $13,803,000 | – | 674,323 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
| Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
| NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
| Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
| Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
| Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
| Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
| Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
| Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
| Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |